PanopticAI has revolutionised patient monitoring by developing the first FDA-cleared app for contactless pulse rate measurement. Using remote photoplethysmography (rPPG) algorithms and smartphone cameras, this innovation eliminates the need for costly medical equipment, making healthcare more accessible and scalable, says GlobalData.
The app provides accurate vital sign readings with a 30-second scan, transforming smartphones into a medical-grade tool. This development marks a shift toward AI-driven, consumer-focused digital health solutions.
Elia Garcia, Medical Analyst at GlobalData, comments, “Beyond its technological innovation, PanopticAI’s FDA recent clearance highlights the importance of Software as a Medical Device (SaMD) within healthcare systems. The app was validated through rigorous testing across diverse patient demographics and environmental conditions, ensuring it works reliably in real-world scenarios. Its adoption by hospitals, insurers, and pharmacies—such as Gleneagles Hospital and Bupa—illustrates the growing demand for accessible, preventive care solutions.”
PanopticAI exemplifies how digital health can bridge gaps in traditional healthcare by simplifying monitoring and reducing costs, especially in underserved populations or regions with limited healthcare resources.
Garcia concludes, “PanopticAI’s breakthrough aligns with key trends, including the increasing consumerisation of healthcare, the proliferation of AI-powered solutions, and the shift toward preventive care. Leveraging everyday devices such as smartphones reduces dependency on expensive wearables, breaking barriers to adoption.”
Edits made by EH News Bureau